A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CT

Nuclear Medicine Communications

Volumn 33, Issue 11, 2012, Pages 1127-1133

  Lu, Yu Yu ^a   Chen, Jin Hua ^b   Ding, Hueisch Jy ^e   Chien, Chun Ru ^c,d   Lin, Wan Yu ^a,c   Kao, Chia Hung ^a,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Biostatistics Center and Graduate Institute of Biostatistics   (Taiwan)

^c School of Chinese Medicine   (Taiwan)

^d Departments of Radiation Therapy and Oncology   (Taiwan)

^e I SHOU UNIVERSITY   (Taiwan)

Author keywords

18F FDG PET; colorectal cancer; meta analysis; PET CT; systematic review

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; LYMPH NODE STAGING; MEDICAL LITERATURE; MEDLINE; META ANALYSIS (TOPIC); POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

COLORECTAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY;

EID: 84866847903     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328357b2d9     Document Type: Review

References (28)

1. Siegel R,Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61:212-236.
2. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004; 96:1420-1425.
3. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
4. Dighe S, Purkayastha S, Swift I, Tekkis PP, Darzi A, A'Hern R, Brown G. Diagnostic precision of CT in local staging of colon cancers: a meta-analysis. Clin Radiol 2010; 65:708-719.
5. Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, et al. Accuracy of whole-body dual-modality fluorine-18-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET-CT) for tumor staging in solid tumors: comparison with CTand PET. J Clin Oncol 2004; 22:4357-4368.
6. Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET/CT in the evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003; 44:1200-1209.
7. Schöder H, Larson SM, Yeung HW. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med 2004; 45:72S-81S.
8. Cohade C, Osman M, Leal J,Wahl RL. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003; 44:1797-1803.
9. Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008; 49:480-508.
10. Cochrane Methods Working Group. Systematic review of screening and diagnostic tests: recommended methods, updated June 6, 1996. Available at: http://www.cochrane.org/cochrane/sadtdoc1.htm [Accessed 22 March 2001].
11. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12:1293-1316.
12. Kang S, Kim SK, Chung DC, Seo SS, Kim JY, Nam BH, Park SY. Diagnostic value of (18)F-FDG PET for evaluation of para-aortic nodal metastasis in patients with cervical carcinoma: a meta-analysis. J Nucl Med 2010; 51:360-367.
13. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6:31.
14. Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N. Pre-therapy diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT. Jpn J Clin Oncol 2008; 38:347-353.
15. Gearhart SL, Frassica D, Rosen R, Choti M, Schulick R, Wahl R. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol 2006; 13:397-404.
16. Squillaci E, Manenti G, Mancino S, Ciccio C, Calabria F, Danieli R, et al. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT-initial clinical experience. Abdom Imaging 2008; 33:676-688.
17. Kosugi C, Saito N, Murakami K, Ochiai A, Koda K, Ono M, et al. Positron emission tomography for pre-therapy staging in patients with locally advanced or metastatic colorectal adenocarcinoma in lymph node metastasis. Hepatogastroenterology 2008; 55 (82-83):398-402.
18. Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, Spaulding MB. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998; 206:755-760.
19. Mukai M, Sadahiro S, Yasuda S, Ishida H, Tokunaga N, Tajima T, Makuuchi H. Pre-therapy evaluation by whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer. Oncol Rep 2000; 7:85-87.
20. Kantorová I, Lipská L, Bêlohlá vek O, Visokai V, TrubaĉM, Schneiderová M. Routine (18)F-FDG PET pre-therapy staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 2003; 44:1784-1788.
21. Furukawa H, Ikuma H, Seki A, Yokoe K, Yuen S, Aramaki T, Yamagushi S. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the pre-therapy staging of colorectal cancer. Gut 2006; 55:1007-1011.
22. Llamas-Elvira JM, Rodr?́guez-Fernández A, Gutié rrez-Sá inz J, Gomez-Rio M, Bellon-Guardia M, Ramos-Font C, et al. Fluorine-18 fluorodeoxyglucose PET in the pre-therapy staging of colorectal cancer. Eur J Nucl Med Mol Imaging 2007; 34:859-867.
23. Tateishi U, Maeda T, Morimoto T, Miyake M, Arai Y, Kim EE. Non-enhanced CT versus contrast-enhanced CT in integrated PET/CT studies for nodal staging of rectal cancer. Eur J Nucl Med Mol Imaging 2007; 34: 1627-1634.
24. Akiyoshi T, Oya M, Fujimoto Y, Kuroyanagi H, Ueno M, Yamaguchi T, et al. Comparison of pre-therapy whole-body positron emission tomography with MDCT in patients with primary colorectal cancer. Colorectal Dis 2009; 11:464-469.
25. Ono K, Ochiai R, Yoshida T, Kitagawa M, Omagari J, Kobayashi H, Yamashita Y. Comparison of diffusion-weighted MRI and 2-[fluorine-18]-fluoro-2-deoxy-D- glucose positron emission tomography (FDG-PET) for detecting primary colorectal cancer and regional lymph node metastases. J Magn Reson Imaging 2009; 29:336-340.
26. Kam MH,Wong DC, Siu S, Stevenson AR, Lai J, Phillips GE. Comparison of magnetic resonance imaging-fluorodeoxyglucose positron emission tomography fusion with pathological staging in rectal cancer. Br J Surg 2010; 97:266-268.
27. Kim DJ, Kim JH, Ryu YH, Jeon TJ, Yu JS, Chung JJ. Nodal staging of rectal cancer: high-resolution pelvic MRI versus (18)F-FDGPET/CT. J Comput Assist Tomogr 2011; 35:531-534.
28. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al.; Dutch Colorectal Cancer Group. Pre-therapy radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345:638-646.